{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:20:49Z","timestamp":1791332449789,"version":"4.3.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.ophtha.2012.07.052","type":"journal-article","created":{"date-parts":[[2012,10,11]],"date-time":"2012-10-11T16:27:00Z","timestamp":1349972820000},"page":"186-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":167,"title":["Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated with Juvenile Idiopathic Arthritis: The Systemic Immunosuppressive Therapy for Eye Diseases Study"],"prefix":"10.1016","volume":"120","author":[{"suffix":"II","given":"Anthony C.","family":"Gregory","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Kempen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebenezer","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Oktay","family":"Ka\u00e7maz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Stephen","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Jabs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A.","family":"Levy-Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Nussenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric B.","family":"Suhler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2012.07.052_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1542\/peds.92.2.295","article-title":"American Academy of Pediatrics Section on Rheumatology and Section on Ophthalmology: guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis","volume":"92","year":"1993","journal-title":"Pediatrics"},{"key":"10.1016\/j.ophtha.2012.07.052_bib2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3345\/kjp.2010.53.11.921","article-title":"Pathogenesis and clinical manifestations of juvenile rheumatoid arthritis","volume":"53","author":"Hahn","year":"2010","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.ophtha.2012.07.052_bib3","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/art.20945","article-title":"Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease","volume":"52","author":"Ravelli","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2012.07.052_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00417-005-0087-3","article-title":"Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature","volume":"244","author":"Carvounis","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.07.052_bib5","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1542\/peds.2006-0421","article-title":"American Academy of Pediatrics Section on Rheumatology, Section on Ophthalmology","volume":"117","author":"Cassidy","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ophtha.2012.07.052_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/bjo.86.1.51","article-title":"An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood","volume":"86","author":"Edelsten","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.07.052_bib7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0002-9394(02)02148-7","article-title":"Visual loss associated with pediatric uveitis in English primary and referral centers","volume":"135","author":"Edelsten","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.07.052_bib8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/art.22381","article-title":"Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study","volume":"56","author":"Saurenmann","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2012.07.052_bib9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaapos.2008.03.007","article-title":"Course, complications, and outcome of juvenile arthritis-related uveitis","volume":"12","author":"Sabri","year":"2008","journal-title":"J AAPOS"},{"key":"10.1016\/j.ophtha.2012.07.052_bib10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ajo.2006.11.025","article-title":"Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis","volume":"143","author":"Woreta","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.07.052_bib11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0161-6420(97)30329-7","article-title":"Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis","volume":"104","author":"Dana","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.07.052_bib12","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ajo.2007.01.033","article-title":"Juvenile idiopathic arthritis (JIA)-associated uveitis: incidence of ocular complications and visual acuity loss","volume":"143","author":"Thorne","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.07.052_bib13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0161-6420(96)30682-9","article-title":"Changing patterns in uveitis of childhood","volume":"103","author":"Tugal-Tutkun","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.07.052_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0039-6257(90)90026-R","article-title":"Juvenile arthritis and uveitis","volume":"34","author":"Kanski","year":"1990","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.07.052_bib15","first-page":"394","article-title":"Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis","volume":"30","author":"Bowyer","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ophtha.2012.07.052_bib16","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.ophtha.2005.01.044","article-title":"Analysis of pediatric uveitis cases at a tertiary referral center","volume":"112","author":"Kump","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.07.052_bib17","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.ophtha.2009.05.002","article-title":"Epidemiology and course of disease in childhood uveitis","volume":"116","author":"Smith","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.07.052_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09286580701585892","article-title":"Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study","volume":"15","author":"Kempen","year":"2008","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ophtha.2012.07.052_bib19","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ophtha.2012.07.052_bib20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.07.052_bib21","series-title":"Analysis of Survival Data","author":"Cox","year":"1984"},{"key":"10.1016\/j.ophtha.2012.07.052_bib22","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/01621459.1989.10478874","article-title":"The robust inference for the Cox proportional hazards model","volume":"84","author":"Lin","year":"1989","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ophtha.2012.07.052_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/09273940590951061","article-title":"Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis","volume":"13","author":"Yu","year":"2005","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2012.07.052_bib24","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.ophtha.2005.02.020","article-title":"Mycophenolate mofetil therapy for inflammatory eye disease","volume":"112","author":"Thorne","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.07.052_bib25","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ajo.2008.04.035","article-title":"Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence","volume":"146","author":"Kempen","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.07.052_bib26","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.ophtha.2008.04.026","article-title":"Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation","volume":"115","author":"Galor","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.07.052_bib27","doi-asserted-by":"crossref","first-page":"b2480","DOI":"10.1136\/bmj.b2480","article-title":"Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study","volume":"339","author":"Kempen","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2012.07.052_bib28","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajo.2009.05.008","article-title":"Azathioprine for ocular inflammatory diseases","volume":"148","author":"Pasadhika","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.07.052_bib29","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ophtha.2009.04.020","article-title":"Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study","volume":"116","author":"Gangaputra","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.07.052_bib30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ajo.2009.09.026","article-title":"Mycophenolate mofetil for ocular inflammation","volume":"149","author":"Daniel","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.07.052_bib31","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2009.08.010","article-title":"Cyclosporine for ocular inflammatory diseases","volume":"117","author":"Kacmaz","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.07.052_bib32","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ophtha.2009.06.060","article-title":"Cyclophosphamide for ocular inflammatory diseases","volume":"117","author":"Pujari","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.07.052_bib33","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ophtha.2011.07.027","article-title":"Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the Multicenter Uveitis Steroid Treatment Trial","volume":"118","author":"Kempen","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.07.052_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00347-010-2260-2","article-title":"Therapy for childhood uveitis: biologics: too often\u2013too late [in German]?","volume":"108","author":"Mackensen","year":"2011","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.ophtha.2012.07.052_bib35","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/S0161-6420(96)30417-X","article-title":"Prognosticators for visual outcome in sarcoid uveitis","volume":"103","author":"Dana","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.07.052_bib36","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1055\/s-2005-858753","article-title":"Epidemiology of uveitis in juvenile idiopathic arthritis from a national paediatric rheumatologic and ophthalmologic database [in German]","volume":"222","author":"Heiligenhaus","year":"2005","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.ophtha.2012.07.052_bib37","first-page":"2031","article-title":"Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis","volume":"24","author":"Chalom","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ophtha.2012.07.052_bib38","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.07.052_bib39","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0161-6420(87)80007-6","article-title":"Prognostic factors in the uveitis of juvenile rheumatoid arthritis","volume":"94","author":"Wolf","year":"1987","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642012006872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642012006872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:03:19Z","timestamp":1758981799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642012006872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0161642012006872"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2012.07.052","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718052286.793481330","asserted-by":"object"}]},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated with Juvenile Idiopathic Arthritis: The Systemic Immunosuppressive Therapy for Eye Diseases Study","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2012.07.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}